Stéphane Bancel
Stéphane Bancel | |
|---|---|
| Born | July 20, 1972 Marseille, France |
| Occupation | Business executive |
| Years active | 1990s–present |
| Known for | CEO of Moderna |
Stéphane Bancel (born 20 July 1972) is a French corporate leader serving as the CEO of the American biotechnology and pharmaceutical firm Moderna, widely recognized for its development of a COVID-19 vaccine. Prior to his role at Moderna, he led the French diagnostics company BioMérieux as CEO. Additionally, Bancel is a partner at Flagship Pioneering and has held board positions with Indigo Agriculture, Boston's Museum of Science, and Qiagen. As of May 2023, his net worth was approximated at US$4.1 billion, with an ownership stake close to 8% in Moderna.
Early life
Originating from Marseille, France, Bancel was raised by an engineer father and a mother who was a physician. From an early age, he demonstrated enthusiasm for computing, mathematics, and scientific disciplines. He attained master's degrees in engineering from CentraleSupélec (previously known as École Centrale Paris) and in biological engineering from the University of Minnesota, followed by earning an MBA at Harvard Business School.
Career
Bancel started his professional journey as sales director at Eli Lilly and Company and later advanced to oversee operations in Belgium. In 2007, he assumed the CEO position at the diagnostics firm BioMérieux, where he successfully enhanced the company’s profitability. In 2011, he took on the role of CEO at Moderna, where he established a notably confidential organizational culture with minimal external scrutiny of its scientific research.
Personal life
He is a father of two children. In April 2020, amidst Moderna’s stock price increase following positive phase 2 trial results for its COVID-19 vaccine, his nearly 9% shareholding surpassed a valuation of $1 billion. Bancel currently lives in Boston, Massachusetts.